Optimizing Multiple Myeloma Treatment and Supportive Care: Discerning the Role of Available and Investigational Pharmacotherapies
This webcast is based on live proceedings from the Pharmacy Learning Network 2012 Conference Series.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Christopher A. Fausel, PharmD, BCPS, BCOP
Indiana University Health
David G. Frame, PharmD
Clinical Hematology, Oncology, and Bone Marrow Specialist
University of Michigan
Ann Arbor, Michigan
This activity is designed for health-system pharmacists.
After completing this activity, participants should be able to:
- Examine the characteristics and clinical and economic burden of multiple myeloma (MM)
- Differentiate current MM treatment standards and algorithms for first-line, refractory, and maintenance therapy
- Evaluate the clinical profiles of investigational therapies for MM management
- Implement supportive-care strategies to improve MM patient care
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Release date: December 17, 2012
Expiration date: December 17, 2013
Estimated time to complete: 1 hour
There is no fee associated with this activity.
This educational activity is a knowledge-based activity.
For questions regarding this educational activity, please call 609-371-1137.
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to email@example.com.
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is approved for 1.0 contact hours (0.1 CEUs) of continuing pharmacy education (UAN 276-000-12-009-H01-P).
This educational activity is a knowledge-based activity.
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at firstname.lastname@example.org. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Executive Director, Accreditation Services, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Sachin Shah, PharmD, BCOP, FCCP, Associate Professor of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, Texas
The planning committee comprises Christopher A. Fausel, PharmD, BCPS, BCOP, David G. Frame, PharmD, Sachin Shah, PharmD, BCOP, FCCP; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Fausel: Promotional speakers bureau—Millennium Pharmaceuticals
Dr. Frame: Promotional speakers bureau—Celgene, Millennium Pharmaceuticals
Dr. Shah disclosed no relevant financial relationships with any commercial interests.
Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the presentations.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Supported by an educational grant from Millennium Pharmaceuticals, Inc.